Journals / Klinik Psikofarmakoloji Bülteni / 2016 / Cilt: 26 - Sayı: 2

Massive Creatine Kinase Elevation During Antipsychotic Drug Treatment with Olanzapine and Quetiapine

Pages
208–209
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ERSEN, H., MANER, F. (2022). Massive Creatine Kinase Elevation During Antipsychotic Drug Treatment with Olanzapine and Quetiapine. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 2, 208–209. https://ajindex.com/articles/573908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Masi G, Milone A, Viglione V, Mancini A, Pisano S. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature. J Child Adolesc Psychopharmacol 2014;24(10):536-42. [CrossRef] 2. Voros V, Osvath P, Fekete S, Tenyi T. Elevated serum creatine kinase levels in psychiatric practice: differential diagnosis and clinical significance: A brief, practical guideline for clinicians. Int J Psychiatry Clin Pract 2008;12(2):147-50. [CrossRef] 3. Martí-Bonmatí E, San Valero-Carcelén E, Ortega-García MP, Rubini-Puig R. Olanzapine elevation of serum creatine kinase. J Clin Psychiatry 2003;64(4):483-4. [CrossRef] 4. Klein JP, Fiedler U, Appel H, Quante A, Jockers-Scherübl MC. Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry 2006;39(1):39-40. [CrossRef] 5. Marcus EL, Vass A, Zislin J. Marked elevation of serum creatine kinase associated with olanzapine therapy. Ann Pharmacother 1999;33(6):697-700. [CrossRef]